Related references
Note: Only part of the references are listed.Human mesenchymal stem cells promote ischemic repairment and angiogenesis of diabetic foot through exosome miRNA-21-5p
Chen Huang et al.
STEM CELL RESEARCH (2021)
Paraneoplastic Syndromes Associated with Laryngeal Cancer
Alessandra Rinaldo et al.
ADVANCES IN THERAPY (2020)
miR-552 promotes laryngocarcinoma cells proliferation and metastasis by targeting p53 pathway
Jia Gu et al.
CELL CYCLE (2020)
miR-21-5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2C
Zhaohui Yang et al.
FEBS OPEN BIO (2020)
miRNAs, oxidative stress, and cancer: A comprehensive and updated review
Seyed Omar Ebrahimi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
MicroRNA-892a regulates laryngocarcinoma cell proliferation via Dicer
Jinhui Dong et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis
Shenfa Zhuang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function
Yin Hu et al.
THERANOSTICS (2018)
Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
Qiang Li et al.
CELL DEATH & DISEASE (2018)
Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma
Mingzhi Xie et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Treatment with eribulin mesilate could suppress epithelial-mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer - preliminary report of a prospective
T. Utsumi et al.
EUROPEAN JOURNAL OF CANCER (2017)
KLF6 inhibited oral cancer migration and invasion via downregulation of mesenchymal markers and inhibition of MMP-9 activities
Li-Sung Hsu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study
Xianfeng Li et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
All-Atom Four-Body Knowledge-Based Statistical Potentials to Distinguish Native Protein Structures from Nonnative Folds
Majid Masso
BIOMED RESEARCH INTERNATIONAL (2017)
Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation
Kai Qu et al.
SCIENTIFIC REPORTS (2017)
Enhanced miR-9 promotes laryngocarcinoma cell survival via down-regulating PTEN
Eryong Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells
Bijing Mao et al.
MOLECULAR MEDICINE REPORTS (2015)
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Maria J. Serrano et al.
ONCOTARGET (2014)
Correction: Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical Treatment
Si-Yi Zhang et al.
PLoS One (2013)
MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6
Xiangyang Zhang et al.
TUMOR BIOLOGY (2012)
Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways
Ning Kang et al.
CANCER LETTERS (2010)
Safety and radiation-enhancing effect of sodium glycididazole in locoregionally advanced laryngeal cancers previously treated with platinum-containing chemotherapy regimens: A preliminary report
Y. C. Zeng et al.
CANCER RADIOTHERAPIE (2010)
Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma
Jingyuan Ren et al.
EUROPEAN JOURNAL OF CANCER (2010)
Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma
Min Liu et al.
CELL RESEARCH (2009)
The role of KLF6 and its splice variants in cancer therapy
Analisa DiFeo et al.
DRUG RESISTANCE UPDATES (2009)
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma
Steven Yea et al.
GASTROENTEROLOGY (2008)
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
P Dhawan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1
S Benzeno et al.
CANCER RESEARCH (2004)
KLF6, a candidate tumor suppressor gene mutated in prostate cancer
G Narla et al.
SCIENCE (2001)
Share Paper
